SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-028442
Filing Date
2022-08-12
Accepted
2022-08-12 11:37:54
Documents
1
Period of Report
2022-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12224
  Complete submission text file 0000899243-22-028442.txt   17085
Mailing Address ATHYRIUM CAPITAL MANAGEMENT, LP 505 FIFTH AVENUE, FL 18 NEW YORK NY 10017
Business Address
Ferrell Jeffrey (Reporting) CIK: 0001394967 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158736

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Funds GP Holdings LLC (Reporting) CIK: 0001815225 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158738

Mailing Address 505 FIFTH AVENUE FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE FLOOR 18 NEW YORK NY 10017 212-402-6925
Athyrium Opportunities IV Acquisition 2 LP (Reporting) CIK: 0001888848 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158742

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities IV Co-invest 2 LP (Reporting) CIK: 0001941772 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158741

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates IV GP LLC (Reporting) CIK: 0001941773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158739

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates IV LP (Reporting) CIK: 0001941775 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158740

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates IV Co-Invest LLC (Reporting) CIK: 0001941778 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221158737